YCBD CIK: 1644903

cbdMD, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
36.5
FY22:
16.0
FY23:
8.07
FY24:
6.39
FY25:
6.55
(positive)
Change from FY21 to FY25
millions USD
FY21:
88.4
FY22:
24.8
FY23:
8.13
FY24:
4.19
FY25:
3.87
Total assets
Change from FY21 to FY25
millions USD
FY21:
125
FY22:
40.8
FY23:
16.2
FY24:
10.6
FY25:
10.4

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
6.92
FY22:
5.29
FY23:
4.67
FY24:
8.62
FY25:
3.19
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.8
FY22:
4.08
FY23:
2.49
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
103
FY22:
31.4
FY23:
9.03
FY24:
1.96
FY25:
7.23
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
125
FY22:
40.8
FY23:
16.2
FY24:
10.6
FY25:
10.4

All amounts in millions USD Data source:SEC EDGAR